
Adding ipilimumab to pembrolizumab does not improve efficacy in patients with NSCLC
Adding ipilimumab to pembrolizumab does not improve efficacy and is associated with greater toxicity than…
Adding ipilimumab to pembrolizumab does not improve efficacy and is associated with greater toxicity than…
Peter Grimison, University of Sydney For some cancer patients undergoing chemotherapy, the thought of joining…
By Harriet Alexander, SMH. The Chris O’Brien Lifehouse, which was built in 2013 to become…